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Age dependent decline in skeletal muscle function leads to impaired metabolic flexibility
in elderly individuals. Physical activity and testosterone treatment have proven efficient
strategies for delaying this condition. However, a common molecular pathway has not
been identified. Muscle specific miRNAs (myomiRs) regulate metabolic pathways in
skeletal muscle, are regulated by physical activity, and have response elements for
testosterone in their promoter region. We therefore hypothesized that myomiRs would
be regulated in skeletal muscle during aging. We further investigated any potential
gender-dependent regulation of these miRNAs. We found that the myomiRs miR-1,
miR-133a, and miR-133b were increased in skeletal muscle of elderly men compared
to younger men. In addition, miR-133a/133b expression was markedly higher in women
compared to men. Elimination of circulating testosterone in men was associated with
lower levels of miR-133a and miR-133b. A positive regulatory effect of testosterone on
miR-133a/133b expression was confirmed in castrated male C57BL/6J mice and in a model
of primary human myocytes. Yet, an improvement of fitness level in the testosterone
depleted men resulted in a down-regulation of miR133a/b. In conclusion, alterations in
fitness level and circulating testosterone seem to represent two independent regulatory
events where testosterone is a specific regulator of miR-133a/b expression.
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INTRODUCTION
The normal aging process involves a decline in skeletal muscle
function. Several metabolic alterations are associated with aging,
including impaired glucose, lipid and protein metabolism, sub-
sequently leading to metabolic inflexibility and loss of skeletal
muscle function (Ramamani et al., 1999; Gibney et al., 2005;
Frederiksen et al., 2012).
Age related metabolic dysregulation is a multifactorial and
gender specific process, involving decreased physical activity and
alterations in steroid hormonal levels (Booth and Zwetsloot,
2010; Kelly and Jones, 2013). Importantly, physical activity delays
and/or diminishes the age related metabolic alterations inde-
pendently of steroid hormones (Yarasheski, 2003). The steroid
hormone testosterone is synthesized mainly in the testis in men
and to a minor degree in the ovaries in women and plays a
key role in carbohydrate, fat, and protein metabolism in tis-
sues expressing the androgen receptor (AR), including skeletal
muscle (Ramamani et al., 1999; Frederiksen et al., 2012; Phillips
et al., 2012). In men, circulating testosterone levels peak around
age 30–40 and gradually decrease thereafter. At the age of 75,
testosterone levels are approximately decreased by 30%, com-
pared to peak levels (Deslypere and Vermeulen, 1984; Muller
et al., 2003). In adult women, circulating testosterone concen-
trations are approximately 10 times as low as in men (Torjesen
and Sandnes, 2004) and likewise decrease with age (Yasui et al.,
2012). Circulating testosterone can be bound to carrier proteins
but also exist in an unbound form, which is normally referred
to as free testosterone. The molecular mechanisms by which cir-
culating testosterone controls muscle metabolism are not fully
clear.
The canonical pathway through which free testosterone acts is
by diffusing through the cell wall and binding to cytosolic AR’s,
which translocate to the nucleus and bind to DNA as dimers.
Nuclear AR binds to androgen response elements (AREs) within
genomic promoter regions, where it can regulate gene transcrip-
tion (Heemers and Tindall, 2007). Interestingly, AREs have been
identified in the promoter regions of the non-coding regulatory
group of RNAs called microRNAs (miRNAs) (Delic et al., 2010).
Mature miRNAs are typically 20–22bp in length, and function
through physical association with the 3′UTR of a mRNA, either
degrading the mRNA or causing ribosomal stalling to reduce pro-
tein translation (Bartel, 2004). A single miRNA can regulate the
expression of hundreds of mRNAs and proteins (Lim et al., 2005;
Baek et al., 2008) and these small RNAs therefore play a crucial
role in many aspects of biology, including cell cycle regulation,
developmental processes and metabolic regulation (Chen et al.,
2006; Zhao et al., 2007; Gallagher et al., 2010; Lujambio and Lowe,
2012). miR-1, miR-133a, miR-133b, and miR-206 belong to a
group of muscle specific miRNAs (myomiRs) crucial for the reg-
ulation of skeletal muscle development and function (Chen et al.,
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2006; van Rooij et al., 2008). Five active ARE motifs have been
experimentally identified and verified in the promoter region near
the co-transcribed miR-206/miR-133b locus (Wyce et al., 2010).
ARE motifs near the miR-1/miR-133a loci, have not yet been
identified. Importantly, in addition to steroid hormones, myomiR
loci are regulated by muscle specific transcription factors referred
to as Myogenic Regulatory Factors (MRFs) (Chen et al., 2006;
Rao et al., 2006; Sweetman et al., 2008). MRFs are vital in the
process of coordinating skeletal muscle development and repair
(Ramamani et al., 1999). Interestingly, AREs are also foundwithin
the promoters for two of the four MRFs, myogenic differentiation
1 (MYOD1) and myogenin (MYOG), suggesting that androgens
may indirectly alter myomiR transcription (Dubois et al., 2012).
Taken together, transcriptional regulation of myomiRs might be
controlled directly and/or indirectly by androgens.
We have previously shown that the expression of all four
myomiRs decreases in response to an endurance training program
suggesting that these myomiRs are important for metabolic adap-
tation to endurance exercise (Nielsen et al., 2010). Furthermore, a
study by Drummond and co-workers examined myomiR expres-
sion patterns in muscle in relation to aging (Drummond et al.,
2008b). No differences in basal expression of mature func-
tional myomiRs between elderly and younger men were detected.
However, expression of myomiRs in response to resistance exer-
cise and ingestion of essential amino acids was different between
elderly and young men. Therefore, anabolic resistance in aged
skeletal muscle seems to have a different response mechanism
to anabolic stimuli. In addition, myomiR expression is altered
in several mice and human models investigating skeletal mus-
cle atrophy and hypertrophy (Huang et al., 2011; Ringholm
et al., 2011) and miR-206 is specifically down-regulated in mus-
cle of patients with Amyotrophic lateral sclerosis (Russell et al.,
2012).
Interestingly, one validated target of miR-133a/b is the insulin-
like growth factor-1 receptor (IGF-1R) in skeletal muscle (Huang
et al., 2011), making miR-133a/b a likely regulator of growth
factor signaling through the AKT signaling pathway (Schiaffino
and Mammucari, 2011). Furthermore, it has been shown that
miR-133a and miR-206 are lower in skeletal muscle of people
with type 2 diabetes (Gallagher et al., 2010). Therefore, several
pieces of evidence indicate that myomiRs are likely to be involved
in the process of maintaining metabolic flexibility in skeletal
muscle.
Thus, our aim was to investigate whether myomiRs are dys-
regulated in aged skeletal muscle. Based on previous observations
that myomiR expression decreases with increased aerobic fitness
and that aerobic fitness decreases with age (Booth and Zwetsloot,
2010; Nielsen et al., 2010; Keller et al., 2011), we hypothe-
sized that skeletal muscle of older individuals would have higher
myomiR expression. In addition, given that men and women have
markedly different testosterone levels and given a recent report
showing that the transcriptome in aged muscle differs markedly
between genders (Liu et al., 2013), we further investigated poten-
tial differences in myomiR expression between men and women.
Finally, we examined whether testosterone, a hormone delaying
the age dependent decline in muscle function, regulates myomiR
expression.
METHODS
ETHICAL APPROVAL
The human studies (in vivo study 1 and 2) were approved by the
local Ethical Committee of Copenhagen and Frederiksberg (KF
01-141/04) (H-4-2009-102) and were performed in accordance
with the Declaration of Helsinki. The purpose of the study and its
possible risks and discomforts were explained to the participants
before their written consent was obtained.
IN VIVO STUDY 1
Nine older men and nine older women participated in the study.
Before inclusion in the study, a medical examination with blood
test screening, maximal oxygen consumption test (VO2max), and
oral glucose tolerance test were performed. Nine younger men
and nine younger women with similar body mass indexes (BMIs)
as the elderly were recruited as control groups. The control group
underwent the same examinations and tests as the two older
groups before inclusion. Subjects were excluded from the study
if they had any infections 2 weeks before the study or if they were
diabetic or had impaired glucose tolerance. Subject characteristics
are listed in Table 1. All subjects arrived in the morning in a fasted
state to the lab.
IN VIVO STUDY 2
Eight men with prostate cancer undergoing medical clinical cas-
tration, in form of the LHRH-agonist, Goserelin (Zoladex) were
recruited from the Departments of Urology at Rigshospitalet
and Herlev Hospital, as previously described (Hvid et al., 2013).
Briefly, all subjects were treated with Goserelin for at least 3
months before inclusion in the study and continued the treat-
ment throughout the study. Subjects were excluded if they had any
infections 2 weeks before the study started or if they had severe
health threatening metastases. Eight healthy men with normal
testosterone levels, matched for age and VO2max, were recruited
as a control group. Subject characteristics are listed in Table 2. On
the experimental day subjects arrived in the morning in a fasted
state. Testosterone levels were measured before an oral glucose
tolerance test, 3–5 days pre and post-training.
TRAINING PROTOCOL IN VIVO STUDY 2
Subjects from in vivo study 2 performed and endurance train-
ing program for 12 weeks on a cycle ergometer (Monark 839E,
Monark Ltd, Varberg, Sweden) consisting of three training ses-
sions per week. All training sessions consisted of 5min of warm
up, 35min of interval training and 5min of cool down, as previ-
ously described (Hvid et al., 2013). The first 6 weeks the mean
training intensity was at 65% of VO2max,and the last 6 weeks
at 75% of VO2max. All training sessions were supervised and
heart rate was continuously monitored (RS400; Polar, Kempele,
Finland). The subjects were instructed to maintain their habitual
diet and level of physical activity during the study. The subjects
completed the diet and activity records for 3 days in the begin-
ning of the training period and for 3 days at the end of the training
period. Diet did not differ between groups.
BODY COMPOSITION
Whole body fat and fat-free tissue mass measurements were per-
formed using a dual-energy X-ray absorptiometry (DXA) scanner
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Table 1 | In vivo study 1.
Young women (n = 9) Elderly women (n = 9) Young men (n = 9) Elderly men (n = 9) Two-way ANOVA
Age 23±1.5**** 68.1±2.2 21.6±1.8**** 68.1±2.2 ****(Age)
Weight (kg) 63.9±7.8 64.4±8.5 77.1±11.2 81.2±8.7 ****(Gender)
Height (m) 1.7±0.1§§ 1.7±0.1§§ 1.8±0.1§§§§ 1.8±0.1 ****(Gender)
BODY COMPOSITION
BMI 22.3±2.4 23.7±2.7 23.1±2.8 24.6±2.8
Lean body mass (kg) 40.6±5.5§§§§ 39.8±2.7§§§§ 59.8±5.9 58.6±5.0 ****(Gender)
Fat mass (kg) 19.7±4.1 21.5±7.1 13.7±8.3 18.8±7.1
FITNESS
VO2 max (l/min/kg) 35.0±4.1§ 27.7±6.5 45.9±8.1**** 28.2±6.2 ****(Age)
Fitness index (l/min/lbm) 0.9±0.05 0.7±0.05§ 0.8±0.1*** 0.05±0.03 ****(Age)
**(Gender)
HORMONES
Testosterone (nmol/l) 1.8±0.4§§§§ 0.6±0.3§§§§ 24±7.0* 14.4±7.0 ****(Gender)
*(Age)
Estradiol (nmol/l) 0.5±0.5***,§§ 0.04±0.003§§§ 0.1±0.02* 0.1±0.03 *(Gender)
**(Age)
GLUCOSE METABOLISM
Glucose (mmol/l) 4.7±0.2 5.0±0.2 4.8±0.1** 5.4±0.2
Insulin (pmol/l) 43.2±6.5 30.3±4.7 30.9±3.2 40.1±7.1
Glucose OGTT (AUC) 843* 943 846*** 991 *(Age)
Insulin OGTT (AUC) 37264 38931 34623 39010
CHOLESTEROL
Cholesterol (mmol/l) 4.4±0.3* 5.4±0.3 3.9±0.1** 5.3±0.3 ****(Age)
HDL (mmol/l) 1.7±0.1§ 1.9±0.2 1.3±0.1* 1.7±0.1 ***(Gender)
*(Age)
LDL (mmol/l) 2.3±0.2* 3.2±0.3 2.3±0.1** 3.3±0.3 **(Age)
Subject characteristics in old and young females and males. Data are means ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (Between age for each
gender) §P < 0.05, §§P < 0.01, §§§P < 0.001, §§§§P < 0.0001 (between gender for each age group). A separate column shows the overall effect with a two-way
ANOVA (same significance levels as between age).
(Lunar Prodigy, GE Healthcare, WI, Madison USA, software v.
8.8) in both human in vivo studies.
MUSCLE BIOPSIES
Muscle biopsies from vastus lateralis were obtained at rest in the
fasted state using the percutaneous needle method with suction
under local anaesthesia, using 3–5ml of 20mg ml−1 lidocaine
(SAD, Denmark Copenhagen). Muscle tissue was immediately
frozen in liquid nitrogen and stored at −80◦C until further
analysis.
ANIMAL EXPERIMENTAL PROTOCOLS
Nine male 7 weeks old wild-type C57BL/6J mice originally
obtained from Taconic, Denmark and inbred at the animal facility
(Copenhagen, Denmark). All experiments were approved by The
Animal Experiments Inspectorate of Denmark in accordance with
the National Health and Medical Research Council of Australia
Guidelines on Animal Experimentation. Mice were maintained
on a 12-h light, 12-h dark cycle on standard rodent chow diet.
Eight weeks old mice (n = 5) were surgically castrated, eliminat-
ing circulating testosterone. The control mice (n = 4) were sham
operated to obtain equal treatment between groups. Twenty-four
weeks post castration and sham operation the mice were sacri-
ficed and quadriceps muscle was snap frozen in liquid nitrogen
and stored at –80◦C until further use. Quadriceps muscle was
powdered in liquid nitrogen before RNA isolation (see separate
procedure description).
CELL EXPERIMENTS
Satellite cells were isolated from muscle biopsies as previously
described (Scheele et al., 2012). Unless otherwise stated, all
cell culture reagents were from Invitrogen, Carlsbad, CA, USA.
Briefly, a muscle biopsy was obtained from vastus lateralis and
digested in 5ml HamF10 media containing 50% trypsin EDTA
(1×) and 5mg collagenase IV (Sigma-Aldrich, St. Louis, MO,
USA) and BSA (Sigma-Aldrich) at 37◦C for 5min. The diges-
tion solution was inactivated in serum on ice and the pro-
cedure was repeated. The digestion solution was filtered and
centrifuged at 800 g for 7min. Following washing with HamF10,
cells were pre-plated in a 60mm culture plate, to diminish
fibroblast contamination. After 3 h incubation, the cell suspen-
sion was transferred to a 25 cm3 flask coated with matrigel (BD,
Franklin Lakes, NJ, USA). The media, HamF10, 20% FBS, 1%
Penicillin/Streptomycin and 1% Fungizone, was changed on day
4 after isolation and thereafter every second day. Cell cultures
were expanded from the 25 cm3 flask to a 10 cm plate, which were
assigned passage (P) 1. Thereafter, cells were split 1:3 at 75% con-
fluence. Experiments were performed on cells at P6–P7. For dif-
ferentiation, cells were seeded in DMEM low glucose (1 g/L), 10%
FBS, 1% Penicillin/Streptomycin and, upon confluence, media
was changed to DMEM high glucose (4.5 g/L), 2% horse serum,
1% Penicillin/Streptomycin. Experiments were performed on day
6 of differentiation by which time cells had fused into polynu-
cleated myotubes. Differentiated myotubes were then incubated
with 100 nM free testosterone 99% purum (Sigma-Aldrich,
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Table 2 | In vivo study 2.
Control LHRH-agonist
(n = 8) (n = 8)
Age 67.5±2.9 67.9±6.8
Weight (kg) 80.5±12.7 80±13.8
Height (cm) 177.6±4.5 176.1±9.4
BODY COMPOSITION
BMI 25.5±3.3 25.7±3.6
Lean body mass pre-training (kg) 57.27±2.1 52.15±2.5
Lean body mass post-training (kg) 57.32±2.07 52.13±2.4
Fat mass pre-training (kg) 20.2±2.9 24.5±3.8
Fat mass post-training (kg) 19.3±2.7 23.19±2.9
FITNESS
VO2 max pre-training (l/min/kg) 27±3.8 25.3±4.4
VO2 max post-training (l/min/kg) 31.3±3.3**** 29.4±3.9****
HORMONES
Testosterone (nmol/l) 13.5±5.1§§§ 0.5±0.4
Subject characteristics in LHRH-agonist treated prostate cancer patients and
healthy controls. Fitness, lean body mass and fat mass significance levels were
calculated with a Two-Way ANOVA RM and bonferroni’s multiple comparison test
was used as post-hoc test to identify any differences between groups before and
after training. ****P< 0.0001, symbolize overall effect of training. The remaining
significance levels were calculated with unpaired t-tests. §§§P < 0.001 (between
the two groups). Data are means ± SD.
Switzerland) and 5α-androstan-17β-ol-3-one (Sigma-Aldrich,
Switzerland) for 24 h on FBS free low glucose DMEM media
to avoid contamination of testosterone present in the FBS.
Testosterone and 5α-androstan-17β-ol-3-one were dissolved in
Dimethyl Sulphoxide (DMSO) (Sigma-Aldrich, Switzerland) and
thereafter mixed with DMEM media. The vehicle, DMSO, was
added in equal concentrations as the testosterone stimulated cul-
tures. All cell culture experiments were repeated 4 times (n = 4).
RNA ISOLATION
Approximately 30mg skeletal muscle samples, powdered quadri-
ceps muscle (mouse study) or Vastus Lateralis (human stud-
ies) were homogenized in TRIzol (Life Technologies) using a
Tissuelyser (Qiagen, Valencia, CA, USA) and total RNA was iso-
lated according to the manufacturer’s protocol. Total RNA was
dissolved in RNase-free water and quantified using a Nanodrop
ND 1000 (Thermo Scientific, Wilmington, DE, USA).
myomir QUANTIFICATION
The abundance of mature miRNAs was measured using TaqMan
miRNA assays specific for miR-1 (Assay ID: 002222), miR-
133a (Assay ID: 002246), miR-133b (Assay ID: 002247) and
−206 (Assay ID: 000510) according to the manufacturer’s direc-
tions (Applied Biosystems Inc., Foster City, CA, USA). Briefly,
reverse transcription was performed with miRNA-specific RT
primers and 10 ng of total RNA for 30min at 37◦C fol-
lowed by 10min incubation at 95◦C. Quantitative real-time PCR
(qPCR) was performed using the ViiA7 Sequence Detection
System (Applied Biosystems) according to the manufacturer’s
protocol in triplicates, using the RT product and miRNA-
specific PCR primers for 40 cycles. The final miRNA specific
primer assay volume was 5% (20×) of the total volume for the
qPCR, as recommended by the manufacturer’s protocol (Applied
Biosystems). RNU48 (Assay ID: 001006), a small nuclear RNA,
and 18S was measured using the same type of detection assay
(Applied Biosystems), and was used as an endogenous control
for miRNA expression analyses in the human in vivo stud-
ies. Endogenous controls were tested for systematically variation
between samples before further analysis. In the mouse study
18S (Mm03928990_g1) was used as an endogenous control, as
RNU48 is not expressed in mice. RNU48 was used as endoge-
nous control in human in vivo study 2 and in the human primary
myotube in vitro study. In the human in vivo study 1, 18S
expression was used as an endogenous control due to differen-
tially expression of RNU48 between elderly and young subjects.
Expression levels were calculated with the standard curvemethod.
PCR efficiencies, linearity slopes, cycle threshold ranges and con-
centrations for the qPCR primers used in the study are listed in
Table 3.
mRNA QUANTIFICATION
Total RNA (0.5μg) was reverse-transcribed using cDNA high
capacity kit (Applied Biosystems) according to themanufacturer’s
protocol. cDNA samples were loaded in triplicate and qPCR
was performed using ViiA7 Sequence Detection system (Applied
Biosystems, Foster City, CA, USA) according to the manufac-
turer’s protocol using either SYBR chemistry or primer-probe
based pre-optimized detection methods. Primers were designed
using Roche Applied Science Assay Design Center (Roche).
Human primers
AR (CT-range: 23.1–24.5)
Pre-optimized assay from Applied Biosystems (Hs00171172_m)
MYOD (CT-range: 24.2–26.2)
Forward primer—CACTACAGCGGCGACTCC
Reverse primer—TAGGCGCCTTCGTAGCAG
MYOG (CT-range: 21.9–23.9)
Forward primer—GCTCAGCTCCCTCAACCA
Reverse primer—GCTGTGAGAGCTGCATTCG
MYF5 (CT-range: 24.7–26.8)
Reverse primer—CTATAGCCTGCCGGGACA
Reverse primer—TGGACCAGACAGGACTGTTACAT
Mouse primers
Ar (CT-range: 21.3—23.2)
Forward primer—TCGGTGGAAGCTACAGACAA
Reverse primer—TAGACCCTTCCCAGCCCTAA
Myog (CT-range: 24.1–27.2)
Forward primer—GGTGCCCAGTGAATGCAACT
Reverse primer—AGCCGCGAGCAAATGATCT
Myod (CT-range: 22.6–25.2)
Forward primer—CACTCCGGGACATAGACTTGACA
Reverse—CCCCGACGGCTCTCTCTG
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Table 3 | PCR standard curve data.
In vivo study 1 (Figure 1) In vivo study 2 (Figure 3)
Primers Lin. slope Efficiency (%) Range (CT) Primer Lin. slope Efficiency (%) Range (CT) Primer
conc. conc.
miR-1 −3.12 106 18.3–22.3
20X
−3.55 94 21.6–24.9
20X
miR-133a −3.18 104 18.6–22.7 −3.22 103 20.4–23.3
miR-133b −3.49 95 19.6–22.9 −3.27 102 19.7–22.7
miR-206 3.5 95 21.6–24.6 −3.21 104 23.2–26.2
RNU48 - - - - −3.38 98 27.4–30.5
MYOD - - - - −3.42 97 24.9–29.0
F: 300 nM
MYOG - - - - −3.15 105 22.7–26.5
R: 300 nM
MYF-5 - - - - −3.28 101 25.5–29.3
AR - - - - −3.51 95 23.7–28.0
18S −3.26 102 14.7–18.5 F: 300 nM −3.44 97 13.0–17.2
R: 300 nM
Mice study (Figure 4) In vitro study (Figure 5)
miR-1 −3.28 101 18.1–21.8
20X
−3.47 96 28.1–32.3
20X
miR-133a −3.35 99 16.6–20.7 −3.59 92 24.9–29.2
miR-133b −3.35 99 17.2–21.3 3.46 96 24.5–28.7
miR-206 −3.41 97 24.4–27.5 −3.49 95 22.9–27.1
RNU48 - - - - −3.16 105 26.8–30.7
MYOD/Myod −3.25 102 22.8–26.8
F: 300 nM
−3.47 96 22.7–26.9
F: 300 nM
MYOG/Myog −3.83 88 25.3–29.1
R: 300 nM
−3.36 99 20.5–24.5
R: 300 nM
MYF-5/Myf-5 −3.8 84 26.1–31.0 −3.53 94 22.5–26.8
AR/Ar −3.19 104 22.9–25.8 −3.46 96 27.1–31.2
18S −3.36 99 13.4–17.4 −3.5 95 13.7–18.1
PCR efficiency, linearity slope, cycle threshold range and concentration for each primer used in the study.
Myf5 (CT-range: 26.3—29.1)
Forward primer—GCCAGTTCTCCCCTTCTGAGTS
Reverse primer—ACTGGTCCCCAAACTCATCCT
Pre-optimized assays from Applied Biosystems for 18S rRNA
(Human, Hs99999901_s1. Mouse, Mm03928990_g1) was used as
endogenous control. To assess amplification efficiency, two fold
serial dilutions were performed for all primers. Based on these,
cDNA was diluted 1:10 for Myog, MyoD,Myf-5, and Ar and 1:200
for 18S, to ensure linear amplification. Melting curve analysis was
performed to ensure primer specificity for SYBR green reactions.
Expression levels were calculated with the standard curve method
(Table 3).
Statistical analysis
The statistical analysis was performed using GraphPad Prism
6.0 (GraphPad Software Inc., La Jolla, CA, USA). Results in the
figures are presented as means ± SEM. Data in the tables are
presented as means ± SD. All data were tested for normality
of distribution before further analysis using the Kolmogorov–
Smirnov test. An ordinary Two-Way ANOVA model 1 was used
to analyse the data in Figure 1 and Table 1 (age and gender
as main effects) and Two-Way ANOVA repeated measures was
used for Figure 3. Bonferroni’s multiple comparisons test was
used as post-hoc tests to identify differences expression within
the two gender groups when the Two-Way ANOVA tests reached
significant level P < 0.05. Unpaired t-tests were used to anal-
yse the data in the mice study (Figure 4), the cell culture study
(Figure 5) and the pre-training expression levels of the myogenic
markers (MYOD, MYOG, MYF5) and the androgen receptor
(AR) (Figure 3). Linear regression analysis was applied as stated
in the legends Figure 2, P < 0.05 was used as significance level.
RESULTS
GENDER AND AGE AFFECTS miR-133a AND miR-133b EXPRESSION
To examine whether age and/or gender affects myomiR expres-
sion in skeletal muscle, we measured myomiRs at rest in biopsies
taken from vastus lateralis in young and elderly men and women
(Figure 1). An ordinary Two-Way ANOVA revealed a markedly
effect of both gender and age on miR-133a and miR-133b expres-
sion (P < 0.01), where both factors are associated with an overall
higher expression of both mature miRNA transcripts. Where no
effect of age and/or gender on miR-1 andmiR-206 expression was
detected (P > 0.05), a significant interaction on miR-1 expres-
sion was identified with a Two-Way ANOVA test (P < 0.05). As
expected, muscle mass was clearly lower in the women (Table 1).
Interestingly, an association between increased muscle mass and
downregulation of myomiRs has been reported (McCarthy and
Esser, 2007). Other variables that might be related to myomiR
expression included aerobic fitness and testosterone levels, which
differed between the four groups (Table 1) and were therefore
selected for additional examination.
miR-1, miR-133a AND miR-133b EXPRESSION IS UPREGULATED WITH
AGING IN MEN
To address a potential involvement of miR-1, miR-133a, and
miR-133b in the age-related decline in muscle function for both
genders, we used a bonferroni multiple comparison post-hoc test.
www.frontiersin.org January 2014 | Volume 4 | Article 394 | 5
Nielsen et al. Age regulated miRNAs in skeletal muscle
FIGURE 1 | MyomiR expression in human skeletal muscle from elderly
and younger individuals. Muscle biopsies were obtained from a cohort
of healthy elderly and younger men and women (n = 9 in each group) and
myomiR levels were measured by using qPCR. An ordinary Two-Way
ANOVA revealed an overall effect of both gender and age on miR-133a and
miR-133b expression (B,C) (∗∗P < 0.01) and a significant interaction for
miR-1 expression (∗∗P < 0.01). When using Bonferroni multiple comparison
post-hoc test it was demonstrated that miR-1 (A), miR-133a (B), and
miR-133b (C) expression levels were higher in elderly compared to
younger men (∗P = 0.02, ∗P = 0.03, ∗∗∗P = 0.008, respectively) There was
no effect of age or gender on mir-206 expression (D) (P > 0.05). Data are
mean ± SEM.
We found an increased expression of miR-1 (P = 0.02), miR-
133a (P = 0.03) and miR-133b (P = 0.008) in elderly men com-
pared to younger men (Figures 1A–C). A Two-Way ANOVA
revealed no effect of age, gender or neither any interaction (P >
0.05) on miR-206 expression and therefore no post-hoc test was
performed within the gender groups (Figure 1D). No significant
differences in expression of any of the three myomiRs in women
were detected (P > 0.05) (Figures 1A–C). Interestingly, similar
to the observed myomiR expression pattern, we identified age
related differences in fasting and OGTT plasma glucose levels in
men but not in women (Table 1).
myomiR EXPRESSION IS NEGATIVELY CORRELATED WITH
TESTOSTERONE AND FITNESS LEVELS
In line with our previous findings (Nielsen et al., 2010) aero-
bic fitness in all subjects was negatively correlated with miR-1
andmiR-133a andmiR-133b (Figures 2A–C) (P < 0.05, 0.01 and
0.001, r2 = 0.11, 0.24, and 0.33, respectively). Furthermore, cir-
culating testosterone levels in men was negatively correlated with
miR-133a and miR 133b expression (Figures 2F,G) (P < 0.05,
r2 = 0.33 and P < 0.05, r2 = 0.26). miR-206 expression in men
was not correlated with testosterone levels or the subjects’ max-
imal oxygen capacity. myomiR expression was not correlated
with testosterone levels in women (data not shown). Thus, we
conducted subsequent experiments addressing the potential role
that circulating testosterone and/or aerobic fitness might play in
regulating skeletal muscle miR-133a/b in men.
miR-133a AND miR-133b ARE DOWN-REGULATED IN TESTOSTERONE
BLOCKED PARTICIPANTS
To test whethermyomiR expression was regulated by testosterone,
aerobic exercise or both, we measured myomiR expression in
vastus lateralis of LHRH-agonist treated prostate cancer patients
and healthy controls matched for maximal oxygen consumption
(Table 2). In addition, myomiR expression was measured after a
12 week aerobic exercise training programme to test if increased
fitness level altered myomiR expression independent of plasma
testosterone levels. Muscle biopsies were obtained at rest before
and after the training period. Partly in line with our previous
results (Nielsen et al., 2010), a Two-Way ANOVA (RM) demon-
strated a main effect of training in terms of decreased expres-
sion in all four myomiRs (miR-1, P < 0.0001. miR-133a, P <
0.01. miR-133b, P < 0.0001, miR-206 P < 0.05). Surprisingly,
a bonferroni multiple comparison test revealed reduced miR-
133a/b expression (miR-133a, P = 0.02. miR-133b, P = 0.03.)
before training in the LHRH-agonist treated participants with
almost no plasma testosterone (Figures 3B,C). That observation
was in opposition to the association observed in the elderly vs.
young participants in study 1 (Figures 2F,G). miR-1 and miR-206
expression were not altered by LHRH-agonist treatment before
the training period (P > 0.05) (Figures 3A,D). Regardless of pre-
exercise intervention level, training equalized the expression of
miR-133a and miR-133b between healthy and LHR-treated par-
ticipants to a lower level. An overall effect of LHRH-agonist treat-
ment was observed for miR-133a and miR-133b expression (P <
0.05), but not in miR-1 or miR-206 expression (P > 0.05). No
significant interaction was observed in any of the four myomiRs,
(P > 0.05). As mentioned in the introduction, testosterone may
indirectly regulate myomiRs through increasing transcription of
the MRFs MYF5, MYOD, and MYOG and the androgen receptor
(AR) (Chen et al., 2006; Sweetman et al., 2008; Wannenes et al.,
2008; Dubois et al., 2012; Nasipak and Kelley, 2012). We therefore
measured mRNA levels of these genes at rest. Intriguingly, while
most of the transcription factors remained unchanged the expres-
sion of MYOG was significantly higher in the LHRH-treated
patients (Figure 3E).
miR-133a AND miR-133b ARE DOWN-REGULATED IN CASTRATED MICE
As our humanmodel included subjects with cancer andwere lack-
ing appropriate controls, we were concerned about non-specific
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FIGURE 2 | Linear regression analysis between myomiR expression
and physiological characteristics. The cohort described in Figure 1
was assessed for associations between muscular miRNA expression
and physiological characteristics. In panel (A–D) are men symbolized
() and women are symbolized (). In panel (D,E) observations
from elderly men are symbolized (•) and observations from younger
men are symbolized (©). miR-1, miR-133a, and miR-133b (A–C) were
inversely correlated with maximal oxygen uptake in women and men
(n = 36) (P < 0.05, 0.01 and 0.001, R2 = 0.11, 0.24, and 0.33). In
addition, miR-133a (F) and miR-133b (G) expression were negatively
correlated with testosterone levels in men (n = 18) (P < 0.05,
R2 = 0.33 and P < 0.05, R2 = 0.26). miR-1 (E) and miR-206 (H)
expression were not correlated with testosterone in men. Data are
mean ± s.e.m.
effects. Therefore, we also measured myomiR expression in
skeletal muscle of castrated mice, which eliminated circulating
testosterone, and sham operated control mice. Consistent with
our findings in the LHRH-agonist treated men with low
circulating testosterone, castrated mice had a lower expression
of mir-133a (P < 0.05) and mir-133b (P < 0.001) (Figure 4A).
The expression of mir-1 and mir-206 were identical in skele-
tal muscle in both castrated and sham operated mice (P >
www.frontiersin.org January 2014 | Volume 4 | Article 394 | 7
Nielsen et al. Age regulated miRNAs in skeletal muscle
FIGURE 3 | MyomiR expression in testosterone depleted men before
and after training. MyomiR expression in the skeletal muscle of LHRH
agonist treated prostate cancer patients (n = 8) and healthy controls
(n = 8), in resting samples prior to and following 12 weeks of aerobic
exercise training. A Two-Way ANOVA (RM) (miR-1, ∗∗∗∗P < 0.0001.
miR-133a, ∗∗P < 0.01. miR-133b, ∗∗∗P < 0.001, miR-206 ∗P < 0.05).
Bonferroni multiple comparison post-hoc tests revealed a significant lower
expression of mir-133a (B) (∗P = 0.02) and mir-133b (C) (∗P = 0.03), but
not mir-1 (A) or miR-206 (D) in testosterone blocked patients at rest
before training. The expression of myomiRs in testosterone blocked
patients and healthy controls were identical after the training period. The
expression of MYOG (E) (∗P < 0.05) at rest was upregulated in
testosterone-blocked participants. No regulation of MYOD, MYF-5, or AR
was detected. Data are mean ± SEM.
0.05). Furthermore, the MRFs measured in castrated mice were
unchanged with the exception of increased Myog mRNA lev-
els, in line with the finding in our testosterone blocked human
participants (P < 0.05) (Figure 4B).
5α-DIHYDROTESTOSTERONE REGULATES miR-133a, miR-133b, AND
miR-206 EXPRESSION IN HUMAN PRIMARY MYOCYTES
To evaluate if testosterone directly regulates myomiR expression
in skeletal muscle we established a cell culturemodel using human
myotubes. Human myotubes were incubated with 100 nM of
testosterone or 100 nM 5α-dihydrotestosterone (5α-DHT), which
has a higher AR affinity than testosterone (Saartok et al., 1984).
5α-DHT is formed in vivo by 5α-reductase acting on testosterone
intracellularly in myocytes (Sato et al., 2008). Whether testos-
terone is converted to 5α-DHT in vitro is unknown, and thus we
incubated primary myotubes with either testosterone or 5α-DHT
for 24 h (Sato et al., 2008). Consistent with the in vivo experi-
ments suggesting a role for testosterone in regulating miR-133a/b,
5α-DHT incubation in culture increasedmiR-133a andmiR-133b
(P < 0.05) (Figure 5A). Surprisingly, incubation with 5α-DHT
decreased miR-206 (P < 0.05), While MYF-5 was upregulated in
response to testosterone or 5α-DHT (P < 0.05), AR, MYOG, and
MYOD mRNA was not significantly altered (Figure 5B).
DISCUSSION
In the current study, we found that the expression of miR-
1, miR-133a, and miR-133b was higher in the skeletal muscle
of elderly compared to younger men and that miR-133a/b was
higher expressed in women compared to men. miR-133a/b was
inversely correlated with an age-dependent decrease of testos-
terone in men. However, our subsequent studies demonstrated
that testosterone positively regulatedmiR-133a/b. Finally, our data
suggest that increased physical activity compensates for the loss of
testosterone in terms of myomiR regulation.
Our collective data from three independent models, indicate
that testosterone up-regulates miR-133a, and 133b. Importantly,
we also show that physical activity overrides the regulatory effect
of testosterone on miR-133a/b expression. Our findings sug-
gest that an age-dependent decline in testosterone and increase
of miR-133a/b expression are independent events. It has been
established that increased physical fitness is associated with a
down-regulation of myomiRs (Nielsen et al., 2010; Keller et al.,
2011). Therefore, it is likely that the decline in physical activ-
ity is the main determining factor involved in the age-dependent
up-regulation of miR-1 and miR-133a/b.
The observed effects of testosterone and age as inducers of
miR-133a and miR-133b expression are seemingly in opposition.
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FIGURE 4 | Muscle of castrated (n = 5) and sham operated (n = 4)
C57BL/6J mice. An unpaired t-test demonstrated a significant lower
expression of mir-133a (∗P < 0.05) and mir-133b (∗∗∗P < 0.001) in the
skeletal muscle of castrated mice. The expression of mir-1 and
mir-206 were not significantly different between castrated and sham
operated mice (A). Whereas the expression of Myog was
upregulated (∗P < 0.05) in castrated mice, no regulation of Myod,
Myf-5, or Ar was detected (P > 0.05) (B). Data are mean ± SEM.
FIGURE 5 | myomiR expression in testosterone treated human muscle
cells. myomiR expression in differentiated human primary myocytes in
response to 100 nM testosterone (n = 4), and 5α-DHT (n = 4). Control
cultures (n = 4) were added DMSO in same concentrations as testosterone
and 5α-DHT stimulated myocytes. miR-133a/b was upregulated in response
to 5α-DHT treatment and mirR-206 expression was downregulated in
response to to testosterone treatment (∗P < 0.05) (A). Whereas the
expression of Myf-5 was upregulated in response to 5α-DHT and
testosterone (∗P < 0.05) no regulation of Myod, Myog or AR was detected
(B). Data are mean ± SEM.
However, in addition to miR-133a/b, miR-1 was induced in the
elderly group. miR-1 has a specific set off predicted mRNA tar-
gets and the regulatory net-effect will thus differ from the effect of
testosterone-mediated miRNA regulation. It is therefore possible
that myomiR alterations contribute to age-dependent decline in
muscle function. Interestingly, our human data suggests that the
effects of testosterone onmyomiR regulation are minor compared
to the effect of increased physical activity. Androgenic control of
miR-133a/b expression therefore seems to be a separate regula-
tory mechanism that may play a role during certain physiological
conditions, such as physical inactivity.
Studies have shown that alterations in myomiR expression are
associated with both hypertrophy and atrophy in skeletal mus-
cle (Care et al., 2007; McCarthy and Esser, 2007). Importantly,
age related loss of muscle mass has been extensively described
in the literature, including the age intervals for the subjects
in the current study (Forbes and Reina, 1970). However, our
elderly subjects were healthy and we did not observe any age
related differences in lean body mass within each gender group
in the current study. Therefore, changes in myomiR expression
might represent an early event preceding potential loss in mus-
cle mass. Noteworthy, lean body mass is assumed to reflect the
muscle mass of the subjects but this assumption is subject to
some degree of uncertainty. A study by Loon and co-workers
revealed thatmuscle cross sectional area andmuscle fiber type size
were markedly decreased in older subjects compared to young.
However, differences in lean body mass between young and old
when performing DXA scan measurements, was not detectable
(Nilwik et al., 2013). Determination of lean body mass by DXA is
an indirect quantification method and not a direct measurement
of the actual muscle mass or cross sectional area, two physiolog-
ical parameters directly related to muscle function. Therefore, it
cannot be excluded that our older participants in fact have suf-
fered from a loss of muscle function that we were not able to
detect in the present cross-sectional study. In contrast to the age
dependent up-regulation of myomiRs in men we did not observe
a similar regulation pattern in women (Figure 1). A possible
explanation for this could be less distinct differences in aero-
bic fitness between the elderly and younger women. Interestingly,
the women had a markedly increase in miR-133a and miR-133b
expression compared to men. Emphasizing the gender differences
of skeletal muscle a recent study by Liu and co-workers demon-
strated that the global transcriptome in muscle of older men
and women differed markedly for groups of genes important for
muscle function (Liu et al., 2013).
A few previous studies have investigated the age dependent
miRNA alteration in human skeletal muscle. Global miRNA
expression in the skeletal muscle of young vs. elderly men was
compared using a miRNA microarray by Drummond et al.
(2011). Drummond found that 18 miRNAs, including miR-
133a and miR-133b, were differentially expressed. In contrast
to our results from the current study, their microarray data
pointed toward a downregulation of miR-133a/b in elderly men.
Interestingly, Drummond et al. have also reported that the
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precursors to mature miRNAs, pri-miR-1, and pri-miR-133a, but
not the mature forms, were increased in skeletal muscle of elderly
men compared to younger controls (Drummond et al., 2008b).
A number of reasons could explain the discrepancy with our
data. In contrast to the study by Drummond et al. the testos-
terone levels in the current study differed between young and
elderly men (Drummond et al., 2008a). Furthermore, aerobic fit-
ness levels were not determined and our young subject group is
approximately 8 years younger than in the study performed by
Drummond and co-workers (Drummond et al., 2008a; Nielsen
et al., 2010).
It is well known that miRNAs frequently are co-expressed in
clusters with neighboring miRNAs (Baskerville and Bartel, 2005).
However, in the current study we observe a co-regulation of
myomiRs from separate loci in response to alterations in circu-
lating testosterone levels. Interestingly, steroid hormonal post-
transcriptional control of miRNA expression in several cell types,
including muscle, has been described in the literature (Yamagata
et al., 2009). Thus, it is possible that the regulation of mir-133a/b
expression by testosterone occurs through a post-transcriptional
processing of the pri- and/or pre-miRNA transcripts.
Our human participants depleted for testosterone were
recently diagnosed with prostate cancer and on LHRH agonist
therapy. Some limitations with this model exist and should be
discussed. For instance, each subject was not his own control
since ethics dictated that treatment was started immediately after
the diagnosis excluding that we could apply a longitudinal study
design. Furthermore, differences between the control and treated
group could be due to the cancer rather than the lack of circulat-
ing testosterone. Therefore, we included two additional models
to verify our findings from the human in vivo study; castra-
tion of male mice which also eliminates circulating testosterone
and stimulation of human myotubes in vitro. These two models
both confirmed our initial findings in the human in vivo model.
We thus show a physiological role of testosterone in the regula-
tion of miR-133a and miR-133b in human and murine skeletal
muscle.
In this study we have examined the myomiR expression in
resting skeletal muscle of elderly and younger men and women
along with the role of testosterone and physical fitness on mus-
cle myomiR regulation. We clearly show that alterations in
testosterone levels are sufficient to alter myomiR expression. We
furthermore conclude that aerobic exercise training is likely to
independently regulate myomiR and seem to override any effects
of testosterone.
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